Belmore Neidrauer LLP

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Silver - Firms: litigation

Finding creative ways to secure optimum results in hard-hitting disputes, Belmore Neidrauer is one of Canada’s premier IP litigation groups and the first port of call for many industry leaders. For example, the team recently represented Janssen against TEVA in a patent infringement action brought under the new PM(NOC) Regulations concerning its schizophrenia medicine. Peter Wilcox and Marian Wolanski brought home the victory. Wilcox has served his clientele with unwavering commitment over the course of his 25-year career, particularly in the pharmaceutical space, and has made several Supreme Court appearances along the way. Wolanski’s training in molecular biology allows her to recognise and deconstruct difficult scientific concerns, all while navigating the complexities of patent litigation. Making her debut in the IAM Patent 1000 this year is Stephanie Anderson, who has been fighting tooth and nail on behalf of Pfizer in an infringement action involving EpiPens. She keeps her cool in court and is a key asset in expert witness cross-examinations.

Patent 1000 Analytics
Analytics and insights
1
Listings in
Jurisdiction
3
Recommended Individuals
In-depth analytics for law firm performance
Patent 1000 Analytics tracks the global legal industry to provide you accurate analysis of the firm's performance. Harness deep data, customizable tools and expert insight to guide strategy, streamline decision-making, and accelerate your business generation.

Unlock unlimited access to all IAM content